Envestnet Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.2M | Sell |
759,743
-55,776
| -7% | -$3.72M | 0.01% | 852 |
|
|
2026
Q1 | $51.2M | Buy |
815,519
+39,015
| +5% | +$2.72M | 0.01% | 793 |
|
|
2025
Q4 | $51.5M | Sell |
776,504
-130,368
| -14% | -$8.43M | 0.02% | 727 |
|
|
2025
Q3 | $61M | Buy |
906,872
+141,601
| +19% | +$11.2M | 0.02% | 686 |
|
|
2025
Q2 | $66.8M | Buy |
765,271
+127,101
| +20% | +$9.96M | 0.02% | 655 |
|
|
2025
Q1 | $43.6M | Buy |
638,170
+54,105
| +9% | +$4.42M | 0.01% | 773 |
|
|
2024
Q4 | $45.4M | Buy |
584,065
+69,535
| +14% | +$5.15M | 0.01% | 764 |
|
|
2024
Q3 | $34.5M | Sell |
514,530
-84,773
| -14% | -$6.96M | 0.01% | 893 |
|
|
2024
Q2 | $67.9M | Buy |
599,303
+3,356
| +0.6% | +$424K | 0.02% | 552 |
|
|
2024
Q1 | $82.7M | Buy |
595,947
+57,520
| +11% | +$7.23M | 0.03% | 493 |
|
|
2023
Q4 | $66.8M | Sell |
538,427
-118,807
| -18% | -$12.1M | 0.03% | 507 |
|
|
2023
Q3 | $61.3M | Buy |
657,234
+72,850
| +12% | +$8.21M | 0.03% | 502 |
|
|
2023
Q2 | $75.1M | Sell |
584,384
-14,926
| -2% | -$1.81M | 0.03% | 415 |
|
|
2023
Q1 | $69.6M | Sell |
599,310
-16,807
| -3% | -$1.88M | 0.03% | 407 |
|
|
2022
Q4 | $69.8M | Sell |
616,117
-15,423
| -2% | -$1.69M | 0.04% | 392 |
|
|
2022
Q3 | $50.9M | Sell |
631,540
-4,761
| -0.7% | -$403K | 0.03% | 432 |
|
|
2022
Q2 | $47.4M | Sell |
636,301
-18,135
| -3% | -$1.66M | 0.03% | 453 |
|
|
2022
Q1 | $83.7M | Buy |
654,436
+6,884
| +1% | +$753K | 0.04% | 346 |
|
|
2021
Q4 | $86.9M | Buy |
647,552
+3,848
| +0.6% | +$553K | 0.04% | 347 |
|
|
2021
Q3 | $88M | Buy |
643,704
+3,192
| +0.5% | +$403K | 0.05% | 320 |
|
|
2021
Q2 | $68.4M | Buy |
640,512
+150,616
| +31% | +$14.5M | 0.04% | 367 |
|
|
2021
Q1 | $44M | Buy |
489,896
+118,460
| +32% | +$11.1M | 0.03% | 443 |
|
|
2020
Q4 | $34.3M | Buy |
371,436
+73,676
| +25% | +$6.58M | 0.03% | 452 |
|
|
2020
Q3 | $30.7M | Buy |
297,760
+38,044
| +15% | +$3.97M | 0.03% | 424 |
|
|
2020
Q2 | $26.3M | Buy |
259,716
+2,896
| +1% | +$259K | 0.03% | 440 |
|
|
2020
Q1 | $17.3M | Buy |
256,820
+14,484
| +6% | +$901K | 0.02% | 502 |
|
|
2019
Q4 | $13.3M | Buy |
242,336
+15,008
| +7% | +$712K | 0.01% | 683 |
|
|
2019
Q3 | $8.48M | Buy |
227,328
+42,188
| +23% | +$1.64M | 0.01% | 815 |
|
|
2019
Q2 | $6.93M | Buy |
185,140
+46,548
| +34% | +$1.46M | 0.01% | 889 |
|
|
2019
Q1 | $4.13M | Buy |
138,592
+17,292
| +14% | +$608K | 0.01% | 1104 |
|
|
2018
Q4 | $3.63M | Buy |
+121,300
| New | +$3.85M | 0.01% | 1044 |
|
|
2018
Q3 | – | Sell |
-17,640
| Closed | -$419K | – | 1599 |
|
|
2018
Q2 | $419K | Buy |
17,640
+24
| +0.1% | +$509 | ﹤0.01% | 1383 |
|
|
2018
Q1 | $327K | Sell |
17,616
-5,028
| -22% | -$74.4K | ﹤0.01% | 1376 |
|
|
2017
Q4 | $324K | Sell |
22,644
-39,728
| -64% | -$516K | ﹤0.01% | 1667 |
|
|
2017
Q3 | $763K | Sell |
62,372
-4,972
| -7% | -$87.9K | ﹤0.01% | 1264 |
|
|
2017
Q2 | $1.23M | Buy |
67,344
+3,552
| +6% | +$65.6K | ﹤0.01% | 1096 |
|
|
2017
Q1 | $1.35M | Sell |
63,792
-7,648
| -11% | -$149K | ﹤0.01% | 1096 |
|
|
2016
Q4 | $1.06M | Sell |
71,440
-49,836
| -41% | -$883K | ﹤0.01% | 1159 |
|
|
2016
Q3 | $2.66M | Buy |
121,276
+76,260
| +169% | +$1.7M | 0.01% | 821 |
|
|
2016
Q2 | $893K | Buy |
45,016
+6,596
| +17% | +$112K | ﹤0.01% | 1370 |
|
|
2016
Q1 | $652K | Buy |
38,420
+4,956
| +15% | +$82.8K | ﹤0.01% | 1520 |
|
|
2015
Q4 | $685K | Sell |
33,464
-1,748
| -5% | -$36.4K | ﹤0.01% | 1468 |
|
|
2015
Q3 | $756K | Buy |
35,212
+1,244
| +4% | +$27.8K | ﹤0.01% | 1410 |
|
|
2015
Q2 | $679K | Buy |
33,968
+5,420
| +19% | +$95.2K | ﹤0.01% | 1582 |
|
|
2015
Q1 | $445K | Buy |
+28,548
| New | +$431K | ﹤0.01% | 1610 |
|
Other funds holding DXCM
Envestnet Asset Management's DXCM Position: Q2 2026 in Review
Envestnet Asset Management reduced its DexCom (DXCM) stake by 6.8% in Q2 2026, selling an estimated $3.72M and leaving 759,743 shares worth $51.2M. The position accounts for 0.01% of the portfolio, ranked #852.
Envestnet Asset Management first reported a position in DXCM in Q1 2015 and has held it in 45 quarters since. The position peaked at $88M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Envestnet Asset Management held 759,743 shares of DexCom worth $51.2M as of Q2 2026.
- Envestnet Asset Management sold 55,776 DexCom shares in Q2 2026, an estimated $3.72M.
- DexCom made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #852 holding.
- Envestnet Asset Management first reported a position in DexCom in Q1 2015 and has held it in 45 quarters since.
- Envestnet Asset Management's DexCom position peaked at $88M in Q3 2021.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.